Boston Collaborative Drug Surveillance Program
GPTKB entity
Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
pharmacoepidemiology research program
|
| gptkbp:affiliatedWith |
gptkb:Boston_University_School_of_Medicine
|
| gptkbp:collaboratedWith |
hospitals in the United States
hospitals in Canada hospitals in the United Kingdom |
| gptkbp:contributedTo |
understanding of drug-induced adverse effects
|
| gptkbp:dataCollected |
over 30 hospitals
|
| gptkbp:dataCollectedPeriod |
1966-1986
|
| gptkbp:established |
1966
|
| gptkbp:focus |
drug safety
pharmacoepidemiology adverse drug reactions |
| gptkbp:foundedBy |
Dr. Lewis B. Sheiner
Dr. William B. Abrams |
| https://www.w3.org/2000/01/rdf-schema#label |
Boston Collaborative Drug Surveillance Program
|
| gptkbp:location |
gptkb:Boston,_Massachusetts
|
| gptkbp:method |
hospital-based surveillance
|
| gptkbp:notableFor |
gptkb:treaty
pioneering large-scale studies of drug safety |
| gptkbp:publishedIn |
gptkb:New_England_Journal_of_Medicine
gptkb:The_Lancet |
| gptkbp:bfsParent |
gptkb:Leon_Jick
|
| gptkbp:bfsLayer |
8
|